Article Text

Download PDFPDF
Pergolide reduced involuntary periodic leg movements and improved sleep in the restless legs syndrome

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Source of funding: Lilly Deutschland GmbH. Drugs provided by Eli Lilly and Company.

  • For correspondence: Dr T C Wetter, Max Planck Institute of Psychiatry, Kraepelinstrasse 10, D-80804 Munich, Germany. FAX +49-89-30622-550.

  • * See glossary.), double-blind, placebo-controlled crossover trial.